HopeStage
Back to all studies
CompletedEUCTR 2016-004023-24

Effect of erythropoietin (EPO) on cognitive function and frontal lobe activity in patients with Bipolarity and unipolar depression in remission (PRETEC-EPO)

This historical record does not confirm current site availability.

Historical research recordDenmark
The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Who was this study for?

This study was for people with bipolarity. Other eligibility criteria applied.

Listed locations
Denmark
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study clarity

Study information

Study start dateNot clearly listed
Recruitment status
Completed
Enrollment listed in the registry
75
Sponsor
Copenhagen Affective Disorder research Center (CADIC), Psychiatric Centre Copenhagen, Rigshospitalet
Sponsor type
Research institute
Study type
Biological
Intervention type
BIOLOGICAL
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Denmark
Age range
Not clearly listed
Official registry ID
EUCTR 2016-004023-24
Official title
Show the full official title

Effect of erythropoietin (EPO) on cognitive function and frontal lobe activity in patients with bipolar disorder and unipolar depression in remission (PRETEC-EPO)

Looking for a study you can join?

Explore recruiting studies

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Completed

Denmark

Registry details
Historical country statuses
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Copenhagen Affective Disorder research Center (CADIC), Psychiatric Centre Copenhagen, Rigshospitalet, a research institute.

Who was this study for?

This study was for people with bipolarity. Other eligibility criteria applied.

Want to explore more studies?

Explore studies